Concepedia

Joel Desharnais

JD

Statistics

Publications

10

Citations

738

H-Index

10

Active since

2001

Affiliations

Scripps Research Institute(Current)

Pennsylvania State University

Pfizer (United States)

Joel Desharnais is an author at Scripps Research Institute specializing in drug discovery, medicinal chemistry, and drug design.

Publications per year

2001–2016

10

Publications

10

Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts

Thorsten Berg, Steven B. Cohen, Joel Desharnais et al. · Proceedings of the National Academy of Sciences · 2002 · 324 citations · Full text

, , +16

Chemical generation of bispecific antibodies

Venkata Ramana Doppalapudi, Jie Huang, Dingguo Liu et al. · Proceedings of the National Academy of Sciences · 2010 · 126 citations · Full text

, , +17

Erythropoietin Mimetics Derived from Solution Phase Combinatorial Libraries

Joel Goldberg, Qing Jin, Yves Ambroise et al. · Journal of the American Chemical Society · 2001 · 67 citations

, , +14

Inhibiting complex IL-17A and IL-17RA interactions with a linear peptide

Shenping Liu, Joel Desharnais, Parag V. Sahasrabudhe et al. · Scientific Reports · 2016 · 55 citations · Full text

, , +17

Rational Design, Synthesis, Evaluation, and Crystal Structure of a Potent Inhibitor of Human GAR Tfase:  10-(Trifluoroacetyl)-5,10-dideazaacyclic-5,6,7,8-tetrahydrofolic Acid<sup>,</sup>

Yan Zhang, Joel Desharnais, Thomas H. Marsilje et al. · Biochemistry · 2003 · 46 citations

, , +13

1–5 of 10